Know Labs, Inc. (NYSEAMERICAN:KNW) Stake Boosted by Callan Capital LLC

Callan Capital LLC increased its stake in Know Labs, Inc. (NYSEAMERICAN:KNW) by 117.6% during the fourth quarter, HoldingsChannel reports. The firm owned 370,000 shares of the company’s stock after acquiring an additional 200,000 shares during the period. Callan Capital LLC’s holdings in Know Labs were worth $188,000 at the end of the most recent quarter.

Analyst Ratings Changes

Separately, Benchmark began coverage on Know Labs in a research note on Monday, April 8th. They set a “speculative buy” rating and a $1.00 target price on the stock.

Know Labs Price Performance

NYSEAMERICAN:KNW traded up $0.03 on Friday, hitting $0.65. 52,393 shares of the company’s stock traded hands, compared to its average volume of 66,342. Know Labs, Inc. has a 1 year low of $0.23 and a 1 year high of $1.48. The stock has a market cap of $52.67 million, a PE ratio of -1.75 and a beta of 1.63.

Know Labs (NYSEAMERICAN:KNW) last released its earnings results on Wednesday, February 14th. The company reported ($0.04) earnings per share for the quarter.

About Know Labs

Know Labs, Inc, together with its subsidiaries, focuses on the development and commercialization of proprietary sensor technology by radio and microwave spectroscopy in the United States. The company's proprietary platform technologies include ChromaID and Bio-RFID technologies that utilizes electromagnetic energy to detect, record, identify, and measure the signature of said materials or analytes.